BioSpace News Archive

Cognito Therapeutics, a clinical-stage company leading the development of a new class of disease-modifying digital therapeutics to treat neurodegenerative disorders including Alzheimer’s disease, announced today the appointment of Mark Day, Ph.D., as Chief Business Officer.

Check-Cap Ltd., a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly preparation-free screening test to detect polyps before they may transform into colorectal cancer, issued the following letter from its chief executive officer, Alex Ovadia to its shareholders and the investment community:

Design Therapeutics, a biotechnology company developing a platform of gene targeted chimera (GeneTAC™) small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions, today announced the successful completion of a $125 million Series B financing, led by Logos Capital.

Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that it has signed a warrant exercise agreement with an existing institutional investor

SetPoint Medical Corporation today announced raising $64M in a Preferred Stock Financing to support its RESET-RA pivotal trial in patients with rheumatoid arthritis (RA).

Ocutrx Technologies, a California-based technology company known for its development pipeline of Oculenz Advanced Macular Degeneration (AMD) patient augmented reality (AR) headset, the ORLenz™ AR surgery headset, and the OR-Bot Surgery Visualization Theatre™, and the Scopetrx™ Wireless Swivel Camera Laparoscopic instrument, has announced the appointment of Dr. William “Bill” Link Ph.D.

Overactive bladder or OAB, affects millions of women of all ages, and can negatively impact nearly every aspect of daily life — from work performance to family life, to social interactions.

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the Solus One E. coli O157 Pathogen Detection Assay for raw ground beef and raw beef trim.

A New York Institute of Technology research team led by Olga V. Savinova, Ph.D., assistant professor of biomedical sciences at New York Institute of Technology College of Osteopathic Medicine (NYITCOM), has secured a five-year grant from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute.

Theralink® Technologies, a precision medicine molecular profiling company with a novel phosphoprotein-based Laboratory Developed Test, announced that it has begun the testing of its first patients with the Theralink’s Reverse Phase Protein Array technology.